The circadian clock regulates many key physiological processes such as the sleep–wake
cycle, hormone release, cardiovascular health, glucose metabolism and body temperature. …

Introduction: MicroRNAs (miRNAs) are small noncoding RNAs that not only regulate gene
expression during normal development but can also be active players in several diseases. To …

Vitamin D is an essential vitamin indispensable for calcium and phosphate metabolism, and
its deficiency has been implicated in several extra-skeletal pathologies, including cancer …

… In recent years, TLRs have gained special attention as promising therapeutic targets for AS.
As the quest for increasingly effective medications is crucial, we discuss the involvement of …

… and its interaction with LDLs, seeking promising therapeutic targets more specifically. … and
cytokines [23], which gradually accumulates during the development of atherosclerosis and …

Voltage-gated Kv1. 3 potassium channels control the membrane potential, cellular activation
and cell death. Kv1. 3 channels have been extensively studied in autoimmune disorders …

… cytokines are involved in macrophage activation, VSMC apoptosis, and direct destruction of
aortic walls. In AAA, both Th1 cytokines and Th2 cytokines are … promising therapeutic targets …

… are promising therapeutic targets to manage patients at risk of developing atherosclerosis. …
MIF activates the expression of various proinflammatory cytokines and chemokines. This …

… and cytokine secretion in monocyte-derived macrophages, and eNOS inhibition and cytokine
… , S1P receptors, particularly S1P 2 , are promising therapeutic targets for atherosclerosis. …

… There is therefore a need to develop a better understanding of the role of cytokines during …
cytokines during atherosclerosis plaque formation. Therapeutic avenues for targeting cytokine …